Our research reveals significant positive correlation between the immune trait CD62L − monocyte %monocyte and risk of osteonecrosis in relative count groups—this relative count reflects its proportion vis-à-vis the corresponding progenitor cell lineage, essentially providing a ratio of CD62L − monocytes to monocytes. The gene discussed is SELL; the disease is osteonecrosis.